Stay updated on Hepatic Impairment Impact on Risdiplam: Clinical Trial
Sign up to get notified when there's something new on the Hepatic Impairment Impact on Risdiplam: Clinical Trial page.

Latest updates to the Hepatic Impairment Impact on Risdiplam: Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the completed risdiplam hepatic-impairment study is now displayed, including its eligibility criteria, locations, study design, outcome measures, results status, and study documents.SummaryDifference55%

- Check11 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previously visible study record. This blocks access to essential details about NCT03920865, such as the study title, conditions, locations, and contacts, effectively removing the core content from the page.SummaryDifference19%

- Check60 days agoChange DetectedA new page revision tag (Revision: v3.7.0) was added, replacing the previous tag (Revision: v3.6.6). This indicates a refreshed version of the page without altering the study details.SummaryDifference0.1%

Stay in the know with updates to Hepatic Impairment Impact on Risdiplam: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Hepatic Impairment Impact on Risdiplam: Clinical Trial page.